Athanor Capital’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-6,136
Closed -$465K 868
2021
Q1
$465K Buy
+6,136
New +$463K 0.01% 499
2020
Q1
Sell
-4,100
Closed -$244K 383
2019
Q4
$244K Buy
+4,100
New +$220K 0.01% 332

Other funds holding SYNH

Athanor Capital's SYNH Position: Q2 2021 in Review

Athanor Capital sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2021, closing a stake of 6,136 shares — an estimated $465K sold.

Athanor Capital first reported a position in SYNH in Q4 2019 and held it in 2 quarters. The position peaked at $465K in Q1 2021. 342 funds tracked by Wall St. Rank hold SYNH as of Q2 2021.

  • Athanor Capital reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2021 after selling out during the quarter.
  • Athanor Capital sold 6,136 Syneos Health, Inc. Class A Common Stock shares in Q2 2021, an estimated $465K.
  • Athanor Capital first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2019 and held it in 2 quarters.
  • Athanor Capital's Syneos Health, Inc. Class A Common Stock position peaked at $465K in Q1 2021.
  • 342 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2021.

Based on Athanor Capital's 13F filing for Q2 2021, filed 16 Aug 2021.